Entries by Marina Belfiore

Peer-reviewed article published in July 2020 American Journal of Health System Pharmacy: “Medication utilization in patients in New York hospitals during the COVID-19 pandemic.”

Agilum has supplied NYU Langone Health and more than 45 other NY health systems – 21% percent of all hospitals in New York state – with the real-world data and analytics methodologies to track, analyze, and predict drug utilization data in real-time during the course of the COVID-19 crisis.

Agilum Healthcare Intelligence’s Data and Analytics Platform Represents a True Paradigm Shift in the Value of Real-World Data and Real-World Evidence for Healthcare Analytics

Agilum’s proprietary Comparative Rapid Cycle Analytics™ (CRCA) platform provided both the analytics and data necessary to help NYU Langone Health evaluate the effectiveness of intravenous acetaminophen (IV APAP) for common orthopedic surgeries. This inaugural study provided answers that not only had the power to influence the formulary assessment, they also served as the basis for a peer-reviewed study published in Hospital Pharmacy this past week.

Agilum takes the spotlight in new ASHP article, “Real-world Data Used to Help Predict Demand for Drug Inventory During Pandemic”

A new feature article in ASHP highlights the importance of real-world data (RWD) to help predict drug demand for the treatment of COVID-19. Hospitals are facing serious challenges as they adapt to the unpredictable disruption of the drug supply chain, and Agilum’s real-world data is enabling them to tackle drug supply issues before they affect patient care.  

Agilum leaders co-author Pharmaceutical Executive article: “Drug Development in Wartime: Driving Tomorrow’s R&D Decisions with Today’s COVID-19 Data”

Agilum’s Chief Executive Officer, Travis Leonardi, RPh, CP, and Chief Medical Information Officer, William Kirsh, DO, MPH, have been featured in Pharmaceutical Executive. The article discusses the challenges of clinical trials during the current COVID-19 pandemic and highlights Agilum’s work to provide real-world data regarding patient drug regimens and survival rates.